Skip to content

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

Teaching Health Promotion and Resilience in Varied Environments: a Peer-led Intervention Following Hospital Discharge

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06843213
Acronym
THRIVE
Enrollment
390
Registered
2025-02-24
Start date
2025-02-18
Completion date
2028-08-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Harm Reduction, Health Promotion, Opioid Use Disorder

Keywords

Opioid Use Disorder, Harm Reduction, Peer Support, Peer Support Specialists

Brief summary

The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving the THRIVE intervention have a reduced risk of self-reported non-fatal overdoses OR skin/soft tissue infections compared to participants receiving enhanced usual care? Researchers will compare the THRIVE model to enhanced usual care to see if the THRIVE model helps participants reduce their number of self-reported non-fatal overdoses OR skin/soft tissue infections. Intervention participants will: * Receive one in-person session from a peer support specialist while in the hospital * Receive weekly text messages from the peer support specialist for a 12-week period * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants Enhanced usual care participants will: * Receive a handout with health resilience education and resources in their local area * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants

Interventions

Participants will receive one peer-led, in-person session boosted by weekly text messages over a 12-week period.

OTHEREnhanced Usual Care

Participants will receive a handout that includes health resilience education and resources in their local area as part of enhanced usual care.

Sponsors

University of Pennsylvania
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Pittsburgh
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants who are: a) admitted to University of Pittsburgh Medical Center (UPMC) Shadyside Hospital, UPMC Presbyterian-Montefiore Hospital, UPMC Mercy Hospital for inpatient or observation status, or b) seen in the Emergency Department setting at UPMC Presbyterian-Montefiore Hospital and UPMC Mercy Hospital. * Participants must have a current diagnosis of Opioid Use Disorder based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria. * Participants must be at least 18 years of age on day of admission. * Participants must be able to speak and read English.

Exclusion criteria

* Participants diagnosed with dementia and/or cognitive impairments. * Participants with acute psychiatric complications, such as schizophrenia with acute psychosis, acute mania, or suicidal ideation (which may impact the ability of a participant to consent and actively participate in treatment). * Participants who are pregnant or lactating at onset of study. * Participants who cannot read or speak English.

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of the THRIVE intervention compared to enhanced usual care (EUC) at lowering the incidence of non-fatal overdoses OR skin and soft tissue infectionsBaseline to 6 monthsCumulative incidence of non-fatal overdose OR skin and soft tissue infection

Secondary

MeasureTime frameDescription
Effectiveness of the THRIVE intervention compared to EUC at lowering the incidence of non-fatal overdosesBaseline to 6 monthsCumulative incidence of non-fatal overdose
Effectiveness of the THRIVE intervention compared to EUC at lowering the incidence of skin and soft tissue infectionsBaseline to 6 monthsCumulative incidence of skin and soft tissue infection

Countries

United States

Contacts

CONTACTResearch Program Coordinator
thriving@pitt.edu412-679-9848
PRINCIPAL_INVESTIGATORJacqueline D Wilson, MD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026